Successful co-treatment with LHRH-agonist for ovarian over-stimulation and cystic formation in premenopausal tamoxifen exposure

By Cohen I.  

Breast Cancer Research and Treatment, Vol. 55, Iss. 2, 1999-05 ,pp. : 117-123

Springer Publishing Company

Access to resources Recommend Favorite

Carboplatin treatment of antiestrogen-resistant breast cancer cells

By        

International Journal of Oncology, Vol. 41, Iss. 5, 2012-01 ,pp. : 1863-1870

Spandidos Publications

Access to resources Recommend Favorite

TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer

By Meijer Danielle  

Breast Cancer Research and Treatment, Vol. 113, Iss. 2, 2009-01 ,pp. : 253-260

Springer Publishing Company

Access to resources Recommend Favorite

Retreatment of recurrent malignant pleural mesothelioma with cisplatin and pemetrexed

By Hayashi Hidetoshi   Okamoto Isamu   Ichikawa Yasuko   Miyazaki Masaki   Yoshioka Hiroshige   Kunimasa Kei   Nakagawa Kazuhiko  

International Journal of Clinical Oncology, Vol. 15, Iss. 5, 2010-10 ,pp. : 497-499

Springer Publishing Company

Access to resources Recommend Favorite

Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors

By Morgan Robert   Synold Timothy   Mamelak Adam   Lim Dean   Al-Kadhimi Zaid   Twardowski Przemyslaw   Leong Lucille   Chow Warren   Margolin Kim   Shibata Stephen   Somlo George   Yen Yun   Frankel Paul   Doroshow James  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 5, 2010-10 ,pp. : 927-933

Springer Publishing Company

Access to resources Recommend Favorite